<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00512915</url>
  </required_header>
  <id_info>
    <org_study_id>B84</org_study_id>
    <nct_id>NCT00512915</nct_id>
  </id_info>
  <brief_title>Avoid FFS - Use of the Atrial Pacemaker Lead 1699 With Very Short Tip Ring Spacing to Avoid Far Field Sensing</brief_title>
  <acronym>Avoid FFS</acronym>
  <official_title>Atriale Vorhofsonde 1699 Mit Sehr Kurzem Bipolabstand Zur Vermeidung Von Far Field Sensing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the possibility to program the shortest possible
      Post Ventricular Atrial Blanking Period (PVAB) and high sensitivity without getting
      inappropriate Mode Switch due to Far Field R-Wave sensing when using the new Tendril 1699T
      lead. Comparison with Tendril 1688T or 1388T with optimized Post Ventricular Atrial Blanking
      (PVAB).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Far-field R-wave sensing (FFS) in the atrial channel of dual chamber pacemakers is a relevant
      source for inappropriate Mode Switch from the DDD mode to the DDI or VDI mode. Inappropriate
      loss of atrioventricular synchrony due to false positive Mode Switch is hemodynamically
      disadvantageous, may induce atrial tachyarrhythmias, can lead to pacemaker syndrome, and
      impairs the reliability of pacemaker Holter data. The aim of the study is to determine
      whether the use of a new atrial screw in lead with ultra short tip-ring distance of 1.1 mm
      (Study Group) eliminates the need for individual adjustment of the postventricular atrial
      blanking period (PVAB) based on an additional test in the Control Group with standard leads.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">August 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of inappropriate mode switch (documented by stored EGM's) using the atrial lead Tendril 1699T with short post ventricular atrial blanking period (PVAB) compared to standard atrial lead (Tentril 1388 or 1688) with optimised PVAB</measure>
    <time_frame>1 and 3 months post implantation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of inappropriate mode switch in respect to lead position and ventricular stimulation frequency</measure>
    <time_frame>1 and 3 months post implantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Atrial Flutter in stored EGM's</measure>
    <time_frame>1 and 3 months post implantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2:1 lock in of Atrial Flutter</measure>
    <time_frame>1 and 3 months post implantation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">204</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Bradycardia</condition>
  <arm_group>
    <arm_group_label>1699T (Optisense)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Implantation of the Optisense Lead 1699T, programming of the shortest possible postventricular atrial blanking period (PVAB)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard lead</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Implantation of a standard bipolar atrial pacing lead. Optimization of the postventricular atrial blanking period (PVAB) after implantation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>pacemaker implantation</intervention_name>
    <description>St. Jude Medical Dual Chamber Pacemaker model Identity (ADx) DR, Victory DR, or newer</description>
    <arm_group_label>1699T (Optisense)</arm_group_label>
    <arm_group_label>Standard lead</arm_group_label>
    <other_name>Active Arm: 1699T Tendril Optisense lead</other_name>
    <other_name>Standard lead: 1688T Tendril SDX, 1788T Tendril ST, 1888T Tendril ST OPTIM</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Indication for dual chamber pacing

          -  Implantation of an Identity (ADX) DR or Victory or later pacemaker (St. Jude Medical)

          -  Bipolar atrial pacing electrode

          -  Age &gt;= 18 years

        Exclusion Criteria:

          -  Persistent / permanent Atrial Arrhythmia

          -  Pacemaker Revision

          -  Pregnancy

          -  Participation in another Study involving active implantable medical devices

          -  Unable to complete follow up

          -  Missing patient informed consent

          -  Cardiac surgery or myocardial infarction within the last 4 weeks

          -  Planned cardiac surgery within 3 months after enrollment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christof Kolb, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Deutsches Herzzentrum Muenchen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinikum Coburg</name>
      <address>
        <city>Coburg</city>
        <zip>96450</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik Fränkische Schweiz</name>
      <address>
        <city>Ebermannstadt</city>
        <zip>91320</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kreisklinik Ebersberg</name>
      <address>
        <city>Ebersberg</city>
        <zip>85560</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Waltershausen-Friedrichroda</name>
      <address>
        <city>Friedrichroda</city>
        <zip>99894</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitäres Herzzentrum Hamburg</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Memmingen</name>
      <address>
        <city>Memmingen</city>
        <zip>87700</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Deutsches Herzzentrum Muenchen</name>
      <address>
        <city>Munich</city>
        <zip>80636</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologische Praxis Dres. med. Bödigheimer / Mühling / Prof. Dr. med. Silber</name>
      <address>
        <city>München</city>
        <zip>80331</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kreiskrankenhaus Ottweiler</name>
      <address>
        <city>Ottweiler</city>
        <zip>66564</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Ulm</name>
      <address>
        <city>Ulm</city>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 7, 2007</study_first_submitted>
  <study_first_submitted_qc>August 7, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2007</study_first_posted>
  <last_update_submitted>March 4, 2009</last_update_submitted>
  <last_update_submitted_qc>March 4, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 5, 2009</last_update_posted>
  <responsible_party>
    <name_title>Jörg Scheiner</name_title>
    <organization>St. Jude Medical GmbH</organization>
  </responsible_party>
  <keyword>Farfield Sensing</keyword>
  <keyword>Pacing lead</keyword>
  <keyword>Postventricular atrial blanking</keyword>
  <keyword>Bradycardia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Bradycardia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

